(Q37278376)

English

Net clinical benefit analysis of radiation therapy oncology group 0525: a phase III trial comparing conventional adjuvant temozolomide with dose-intensive temozolomide in patients with newly diagnosed glioblastoma

scientific article published on 07 October 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Net clinical benefit analysis of radiation therapy oncology group 0525: a phase III trial comparing conventional adjuvant temozolomide with dose-intensive temozolomide in patients with newly diagnosed glioblastoma (English)

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

phase III clinical trial

0 references

Adaptive radiation therapy

0 references

0 references

0 references

object named as

Minesh Mehta

12

0 references

Maria Werner-Wasik

9

object named as

Maria Werner-Wasik

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Andrew Bottomley

6

object named as

Andrew Bottomley

1 reference

Europe PubMed Central

19 August 2017

PMC publication ID

Terri S Armstrong

object named as

Terri S Armstrong

1

1 reference

ORCID Public Data File 2021

author name string

Jeffrey S Wefel

2

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Meihua Wang

3

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Mark R Gilbert

4

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Minhee Won

5

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Tito R Mendoza

7

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Corneel Coens

8

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

David G Brachman

10

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Ali K Choucair

11

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

language of work or name

0 references

publication date

7 October 2013

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Journal of Clinical Oncology

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

31

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

32

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

4076-4084

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816957

6 September 2017

Patient self-reports of symptoms and clinician ratings as predictors of overall cancer survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816957

6 September 2017

Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumab

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816957

6 September 2017

Review on quality of life issues in patients with primary brain tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816957

6 September 2017

An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816957

6 September 2017

The prognostic significance of patient-reported outcomes in cancer clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816957

6 September 2017

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816957

6 September 2017

Normative data for determining significance of test-retest differences on eight common neuropsychological instruments.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816957

6 September 2017

Trail Making Test A and B: normative data stratified by age and education

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816957

6 September 2017

Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816957

6 September 2017

Health related quality of life assessment methodology and reported outcomes in randomised controlled trials of primary brain cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816957

6 September 2017

Normative data for equivalent, parallel forms of the Judgment of Line Orientation Test

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816957

6 September 2017

Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816957

14 September 2017

Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816957

3 September 2018

Validation of the M.D. Anderson Symptom Inventory Brain Tumor Module (MDASI-BT).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816957

3 September 2018

Benton Controlled Oral Word Association Test: reliability and updated norms.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816957

3 September 2018

Construct and concurrent validity of the Hopkins Verbal Learning Test-revised.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816957

3 September 2018

Clinical significance: A statistical approach to defining meaningful change in psychotherapy research

1 reference

https://pubmed.ncbi.nlm.nih.gov/24101048

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1200/JCO.2013.49.6067

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37278376&oldid=2107358188"